Inventor

MOGNA GIOVANNI

IT32 patents

⚠️ This page may combine multiple inventors who share the name “MOGNA GIOVANNI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MOGNA GIOVANNI

PROBIOTICAL SPA

Composition comprising probiotic bacteria for use in the treatment of immune disorders

Composition comprising lactic acid bacteria for use in the preventive and/or curative treatment of recurrent cystitis

Bacterial strains belonging to the genus Bifidobacterium for use in the treatment of hypercholesterolaemia

Lactic acid bacterial composition for the treatment of bacterial vaginal infections by Gardnerella vaginalis and, if present, of concurrent fungal infections

Composition for use in the treatment of major depressive disorder

Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne

Composition for use in the treatment of major depressive disorder

Bacterial composition for use in attenuating the decline in performance after exercise

Compositions comprising live probiotic bacterial cultures of Lactobacillus, Bifidobacterium, Lactococcus, Streptococcus, or Staphylococcus

Compositions for use in the treatment of tumors resistant to chemotherapy

Compositions comprising melatonin and flavonoids for use in the treatment of tumours resistant to chemotherapy

Probiotic bacterial strains and symbiotic composition containing the same intended for infant food

Composition comprising probiotic bacteria for use in the treatment of immune disorders

Treating low production of mucus in the gastrointestinal tract with S. thermophilus

MOGNA GIOVANNI

Folic acid producing bifidobacterium bacterial strains, formulations and use thereof

Conjugated linoleic acid-producing strains of probiotic bacteria and use thereof for the preparation of a food, dietetic or pharmaceutical composition

Composition comprising probiotic bacteria for use in the treatment of immune disorders

Probiotic bacterial strains and symbiotic composition containing the same intended for infant food

Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections

Bacterial strains capable of metabolizing oxalates

Composition comprising N-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach&#39;s own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity

Bacterial strains belonging to the genus bifidobacterium for use in the treatment of hypercholesterolaemia

Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality

Composition for use as a support therapy for treatment of tumours, AIDS and leukaemia

Method for the preparation of anallergic probiotic bacterial cultures and related use

Bacteriocin-producing Lactobacillus pentosus and the use thereof in food and pharmaceutical compositions

Therapy for use in the treatment of tumors, acquired immunodeficiency syndrome and leukemias by dual immune biostimulation

PROBIOTICAL NORTH AMERICA INC

Material impermeable to humidity and oxygen for packaging dietary products, cosmetics and medicinal specialities

Multilayer microencapsulated probiotic bacteria

MOFIN S R L

Production of a yeast-free, highly digestible pizza by using a dough containing lactic acid bacteria

BENASSAI CHIARA

Composition for use in treating or preventing viral or bacterial infections in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy comprising L. reuteri LER03 and/or L. salivarius LS06

ALCE NORTH AMERICA INC

Conjugated linoleic acid-producing strains of probiotic bacteria and use thereof for the preparation of a food, dietetic or pharmaceutical composition

Composition comprising N-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity